PRODUCTS / VERTIGO (MENIERE’S SYNDROME)

acuverBetahistine DiHCI 8 mg/pump stroke,
oral solution

AcuVer®, Bestin®, Marak®

ATC Classification: N07CA01 – Antivertigo preparations – betahistine

Therapeutic indications: For the treatment of vertigo associated with the functional disorders of the vestibular apparatus in the context of Meniere’s symptom complex.

Packsize: Bottles 60 ml and 120 ml

Product registered in: Austria, Bulgaria, Czech Republic, Italy, Poland, Romania, Slovak Republic, Slovenia and Ukraine.

 

For the availability of the product for licensing and/or any other information please contact us.